Mortality after cancer among patients with diabetes mellitus: Effect of diabetes duration and treatment

Diabetologia

Volumn 57, Issue 5, 2014, Pages 927-934

  Ranc, Kristina ^a,b   Jørgensen, Marit E ^a   Friis, Søren ^c   Carstensen, Bendix ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cancer; Diabetes duration; Insulin; Mortality; Oral hypoglycaemic agent; Register study; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

AGED; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CUTANEOUS MELANOMA; DENMARK; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; ESOPHAGUS CANCER; FEMALE; HODGKIN DISEASE; HUMAN; INSULIN TREATMENT; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PLEURA CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; SURVIVAL RATE; TESTIS CANCER; THYROID CANCER; TREATMENT DURATION; UTERINE CERVIX CANCER; UTERINE TUBE CARCINOMA; UTERUS CANCER; BLOOD; COMORBIDITY; COMPLICATION; MIDDLE AGED; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; POISSON DISTRIBUTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; TREATMENT OUTCOME;

AGED; COMORBIDITY; DENMARK; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NEOPLASMS; POISSON DISTRIBUTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TREATMENT OUTCOME;

EID: 84898599065     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3186-z     Document Type: Article

References (23)

1. Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EAM, Møller H (2012) Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 55:1619-1632
2. Carstensen B, Witte DR, Friis S (2012) Cancer occurrence in Danish diabetic patients: duration and insulin effect. Diabetologia 55:948-958
3. Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG (2012) Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 55:1607-1618
4. Wild SH (2011) Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations. Diabetologia 54:1589-1592
5. Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754-2764
6. Currie CJ, Poole CD, Jenkins-Jones S, Gale EAM, Johnson JA, Morgan CL (2012) Mortality after incident cancer in people with and without type 2 diabetes. Diabetes Care 35:299-304
7. Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254-258 (Pubitemid 44106500)
8. Bowker SL, Yasui Y, Veugelers P, Johnson JA (2010) Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia 53:1631-1637
9. Bo S, Ciccone G, Rosato R et al (2011) Cancer mortality reduction and metformin. A retrospective cohort study in type 2 diabetic patients. Diab Obes Metab 14:23-29
10. Baur DM, Klotsche J, Hamnvik OP et al (2010) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in German primary care cohort. Metabolism 60:1363-1371
11. Pedersen CB (2011) The Danish Civil Registration System. Scan J Public Health 39(Suppl 7):22-25
12. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187-2196
13. Carstensen B, Christensen JK, Marcussen MM, Borch-Johnsen K (2011) The National Diabetes Register. Scan J Public Health 39(Suppl 7):58-61
14. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 44:535-539
15. Gjerstorff ML (2011) The Danish Cancer Registry. Scan J Public Health 39(Suppl 7):42-45
16. Carstensen B (2007) Age-period-cohort models for the lexis diagram. Stat Med 26:3018-3045 (Pubitemid 46939424)
17. Plummer M, Carstensen B (2011) Lexis: an R class for epidemiological studies with long-term follow-up. J Stat Softw 38(5):1-12
18. R Development Core Team (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
19. Richardson LC, Pollack LA (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcome of cancer. Nat Clin Pract Oncol 2:48-53 (Pubitemid 40823181)
20. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986-1992 (Pubitemid 46418378)
21. Singh S, Singh PP, Singh AG, Murad H, McWilliams RR, Chari ST (2013) Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Am J Gastroenterol 108:510-519
22. Nguyen-Nielsen M, Froslev T, Friis S, Borre M, Harving N, Sogaard M (2012) Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009. Clin Epidemiol 4:17-23
23. Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39(Suppl 7):30-33